5th REMS Innovation Summit

Join us at the 5th REMS Innovation Summit on July 15-16, 2025, in Washington, D.C., where we’ll explore the evolving role of Risk Evaluation and Mitigation Strategies (REMS) in drug safety.

REMS are specialized safety programs mandated by the FDA for specific medications with serious safety concerns, ensuring their benefits outweigh potential risks. Unlike standard medication labeling, REMS reinforce behaviors and conditions that support safe medication use, helping reduce the occurrence and severity of specific risks.

This year’s summit will feature in-depth sessions and case studies, focusing on how REMS programs are shaping safer drug use practices across healthcare.

Don’t miss this opportunity to connect with industry leaders and peers dedicated to advancing medication safety. Mark your calendars for July 15-16, 2025, and join us in Washington, D.C.!